Immunotherapy and Overall Survival in Advanced NSCLC: A Systematic Review of Randomised Trials

被引：0
|
作者：
Subramaniam, S. [1 ,2 ]
Stockler, M. R. [1 ,3 ]
Kiely, B. E. [1 ,3 ,4 ]
机构：
[1] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[2] Bankstown Canc Ctr, Bankstown, Australia
[3] Concord Canc Ctr, Concord, Australia
[4] Macarthur Canc Therapy Ctr, Campbelltown, NSW, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-29
引用
收藏
页码：S632 / S633
页数：2
相关论文
共 50 条
  • [1] THE IMPACT OF PD1 AND PDL1 IMMUNOTHERAPY ON NSCLC OUTCOMES BEYOND OVERALL SURVIVAL: A SYSTEMATIC REVIEW
    Kanabar, S. S.
    Tiwari, A.
    Soran, V.
    Balendran, P.
    Turner, A. M.
    [J]. THORAX, 2021, 76 : A95 - A95
  • [2] How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review
    Royle, Kara-Louise
    Meads, David
    Visser-Rogers, Jennifer K.
    White, Ian R.
    Cairns, David A.
    [J]. TRIALS, 2023, 24 (01)
  • [3] How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review
    Kara-Louise Royle
    David Meads
    Jennifer K. Visser-Rogers
    Ian R. White
    David A. Cairns
    [J]. Trials, 24
  • [4] Low BMI is Associated with Inferior Overall Survival in HIV Patients with Advanced NSCLC Undergoing Immunotherapy
    Lin, E.
    Kim, S. Y.
    Kuo, D.
    Deng, L.
    Halmos, B.
    Cheng, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S336 - S337
  • [5] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Belin, Lisa
    Tan, Aidan
    De Rycke, Yann
    Dechartres, Agnes
    [J]. BRITISH JOURNAL OF CANCER, 2020, 122 (11) : 1707 - 1714
  • [6] Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-Analysis
    Mauro, Ezequiel
    Sanduzzi-Zamparelli, Marco
    Sauri, Tamara
    Soler, Alexandre
    Iserte, Gemma
    Fortuny, Marta
    Forner, Alejandro
    [J]. CANCERS, 2024, 16 (11)
  • [7] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Lisa Belin
    Aidan Tan
    Yann De Rycke
    Agnès Dechartres
    [J]. British Journal of Cancer, 2020, 122 : 1707 - 1714
  • [8] The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis
    Zhou, Liang
    Wang, Xi-Ling
    Deng, Qing-Long
    Du, Yan-Qiu
    Zhao, Nai-Qing
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [9] The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis
    Liang Zhou
    Xi-Ling Wang
    Qing-Long Deng
    Yan-Qiu Du
    Nai-Qing Zhao
    [J]. Scientific Reports, 6
  • [10] Body Mass Index over Time is Associated with Overall Survival in Advanced NSCLC Patients Treated with Immunotherapy.
    Labomascus, S.
    Fughhi, I.
    Bonomi, P.
    Mcdonald, A.
    Batus, M.
    Fidler, M. J.
    Basu, S.
    Borgia, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S688 - S688
12345